• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Pharmaceutical Product Development

Pharmaceutical Product Development

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. PPD Names Proven Leader for GMP Laboratory Services

    PPD Names Proven Leader for GMP Laboratory Services

  2. X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation

    X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation

  3. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.